Burning Rock Biotech Ltd (BNR) Up 0.96% in Premarket Trading

Burning Rock Biotech Ltd (BNR) has risen Monday morning, with the stock increasing 0.96% in pre-market trading to 1.05. BNR's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Diagnostics & Research industry, which ranks 129 out of 146 industries, the stock ranks higher than 72% of stocks. Burning Rock Biotech Ltd has risen 7.22% over the past month, closing at $0.98 on October 2. During this period of time, the stock fell as low as $0.90 and as high as $1.17. BNR has an average analyst recommendation of Sell. The company has an average price target of $0.90.

BNR has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on BNR!

See Full BNR Report

Burning Rock Biotech Ltd has a Long-Term Technical rank of 37. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 63% of the market scoring higher. In the Diagnostics & Research industry which is number 127 by this metric, BNR ranks better than 127% of stocks.

Important Dates for Investors in BNR:

-Burning Rock Biotech Ltd is set to release earnings on 2023-11-21. Over the last 12 months, the company has reported EPS of $-6.64. -We do not have a set dividend date for Burning Rock Biotech Ltd at this time. Click Here To Get The Full Report on Burning Rock Biotech Ltd (BNR)